ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2704

Neutrophil-Derived Lactoferrin Regulates the Activity of NFAT5 in Rheumatoid Arthritis Synovial Fibroblasts Via Toll-like Receptor 4

Kunihiko Umekita, Shunichi Miyauchi, Kazuyoshi Kubo, Hajime Nomura, Kazumi Umeki, Koushou Iwao, Mao Komura and Akihiko Okayama, Department of Rheumatology, Infectious Diseases and Laboratory Medicine, University of Miyazaki, Miyazaki, Japan

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: innate immunity, neutrophils, pathogenesis and toll-like receptors, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Damage-associated molecular patterns (DAMPs) are proposed to drive aberrant stimulation of Toll-like receptors (TLRs) in the rheumatoid arthritis (RA) joints resulting in increased expression of proinflammatory cytokines and chemokines. In the current study we investigated the role of the neutrophil-derived lactoferrin (LTF), as an endogenous ligand for TLR4 in the inflammatory response of RA synovial fibroblasts (RASF). 

Methods: Recombinant human neutrophil-derived LTF was purchased from Sigma. LTF solution was screened for lipopolysaccharide contamination before using. RASF were treated with LTF and/or TNFα, and the expression of proinflammatory cytokines in RASF was measured by real-time quantitative PCR and multi-cytokine assay system. The levels of phosphorylated p38 mitogen associated phosphokinase (MAPK) in RASF stimulated with LTF were determined by immune blotting. To repress the TLR4 signaling pathway, TAK243, a small molecular inhibitor of TLR4, was used. The role of the nuclear factor of activated T cells 5 (NFAT5) in the TLR4 signaling pathway in RASF was investigated using a small interfering RNA targeting NFAT5.

Results: Stimulation of RASF with LTF significantly increased the mRNA and protein expression of proinflammatory cytokines, such as IL-6, IL-8 and CCL20 (p=0.01). Furthermore, LTF enhanced the expression of IL-6, IL-8, and CCL20 mRNA in RASF stimulated by TNFα (p=0.01). The phosphorylation of p38MAPK increased in LTF-stimulated RASF. TAK243, the TLR4 inhibitor, repressed the expression of proinflammatory cytokines and chemokines in RASF stimulated by LTF. Silencing of NFAT5 significantly decreased the expression of proinflammatory cytokines and chemokines in RASF treated by LTF (p= 0.01).

Conclusion: This is the first study to demonstrate that LTF can induce the proinflammatory response in RASF mediated by TLR4 and the activation of NFAT5. Neutrophil derived LTF is is an endogenous ligand for TLR4  in RASF. The activity of NFAT5 is important in the inflammatory response of RASF induced by LTF via TLR4.


Disclosure: K. Umekita, None; S. Miyauchi, None; K. Kubo, None; H. Nomura, None; K. Umeki, None; K. Iwao, None; M. Komura, None; A. Okayama, None.

To cite this abstract in AMA style:

Umekita K, Miyauchi S, Kubo K, Nomura H, Umeki K, Iwao K, Komura M, Okayama A. Neutrophil-Derived Lactoferrin Regulates the Activity of NFAT5 in Rheumatoid Arthritis Synovial Fibroblasts Via Toll-like Receptor 4 [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/neutrophil-derived-lactoferrin-regulates-the-activity-of-nfat5-in-rheumatoid-arthritis-synovial-fibroblasts-via-toll-like-receptor-4/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neutrophil-derived-lactoferrin-regulates-the-activity-of-nfat5-in-rheumatoid-arthritis-synovial-fibroblasts-via-toll-like-receptor-4/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology